Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 10135-825

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 10135-825). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Marlex Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

825-10 (825 10)

Packaging label for Venlafaxine Hydrochloride Extended-Release Capsules, USP, 37.5 mg strength by Marlex Pharmaceuticals, Inc. The label indicates 1000 capsules per container, oral use, and prescription only. Storage instructions advise keeping at controlled room temperature (20° to 25°C).*

FDA Label Image

825-30 (825 30)

Label for Venlafaxine Hydrochloride Extended-Release Capsules USP 37.5 mg by Marlex Pharmaceuticals, Inc. The label indicates a package of 30 capsules with a US prescription drug designation. Storage instructions specify 20 to 25°C and the product is labeled as a Schedule IV controlled substance. The label includes directions to dispense the enclosed medication guide and warnings to keep out of reach of children, along with manufacturer information in New Castle, DE.*

FDA Label Image

825-75 (825 75)

VENLAFAXINE HYDROCHLORIDE extended-release capsules, 37.5 mg, by Marlex Pharmaceuticals, Inc. The blue and white label shows the medication name, dosage strength, quantity of 15 capsules, and includes storage instructions and usage information. The product is for prescription oral use and comes in a unit-dose package.*

FDA Label Image

825-90 (825 90)

VENLAFAXINE HYDROCHLORIDE Extended-Release Capsules, 37.5 mg, oral capsules. The label shows Marlex Pharmaceuticals, Inc. as the manufacturer. The package contains 90 capsules and is labeled Rx only. It includes storage instructions and dosage guidance referencing the prescribing information, with emphasis on dispensing a medical guide to patients.*

FDA Label Image

826-10 (826 10)

Label for VENLAFAXINE HYDROCHLORIDE Extended-Release Capsules, USP, 75 mg strength, manufactured by Marlex Pharmaceuticals, Inc. The label indicates 1000 capsules per container. It includes storage information to keep at controlled room temperature (20° to 25°C) and a pharmacy instruction to dispense the enclosed Medication Guide to each patient. The label also displays an NDC code and a barcode.*

FDA Label Image

826-30 (826 30)

Venlafaxine Hydrochloride Extended-Release Capsules, USP 75 mg oral capsules in a package of 30 capsules by Marlex Pharmaceuticals, Inc. The label includes instructions to dispense the enclosed Medication Guide and storage information at controlled room temperature 20° to 25°C (68° to 77°F). It also displays the NDC 10135-0826-30 and states 'Rx Only.'*

FDA Label Image

826-75 (826 75)

Packaging label for Venlafaxine Hydrochloride extended-release capsules, USP, 75 mg strength. The label shows a 15-capsule bottle from Marlex Pharmaceuticals, Inc. It includes dispensing instructions for pharmacists, storage conditions at controlled room temperature (20° to 25°C), and a reminder to see accompanying prescribing information. The label is blue, white, and tan with the Marlex Pharmaceuticals logo and a barcode.*

FDA Label Image

826-90 (826 90)

Label for Venlafaxine Hydrochloride extended-release capsules, USP, 75 mg strength. The label shows the product name, dosage form as extended-release capsules, and a package size of 90 capsules. Labeler is Marlex Pharmaceuticals, Inc. The label includes storage instructions (20° to 25°C), dispensing information for pharmacists, a barcode, and manufacturing location in New Castle, DE.*

FDA Label Image

827-10 (827 10)

VENLAFAXINE HYDROCHLORIDE 150 mg extended-release capsules, USP, in a 1000-capsule pack from Marlex Pharmaceuticals, Inc. The label includes storage instructions, pharmacist dispensing information, and a barcode with lot and expiration fields.*

FDA Label Image

827-30 (827 30)

Packaging label for Venlafaxine Hydrochloride Extended-Release Capsules, USP, 150 mg strength, manufactured by Marlex Pharmaceuticals, Inc. The label displays the product name, dosage form as extended-release capsules, strength of 150 mg, and package quantity of 30 capsules. It includes storage instructions, dispensing information for pharmacists, and a barcode.*

FDA Label Image

827-75 (827 75)

Label for Venlafaxine Hydrochloride Extended-Release Capsules, USP 150 mg by Marlex Pharmaceuticals, Inc. The label shows the product name, dosage form, strength, package size of 15 capsules, and storage instructions at 20°C to 25°C. It includes directions to dispense the enclosed Medication Guide and states the product is Rx only.*

FDA Label Image

827-90 (827 90)

Venlafaxine Hydrochloride Extended-Release Capsules, USP 150 mg by Marlex Pharmaceuticals, Inc. The label indicates 90 capsules per bottle and emphasizes that the product is for prescription use only. Additional instructions include storage information and pharmacist dispensing guidelines.*

FDA Label Image

Image (Dcddf00d F2f2 4044 B94a 13658bf2ab59 01)

Chemical structure of venlafaxine hydrochloride, showing the arrangement of atoms including a methoxy-substituted phenyl ring, cyclohexane ring, and amino alcohol moiety associated with the active ingredient venlafaxine hydrochloride.*

FDA Label Image

Image (Dcddf00d F2f2 4044 B94a 13658bf2ab59 02)

A dot plot chart illustrating fold change and 90% confidence intervals for venlafaxine and its ODV metabolite concentrations under various special population conditions. The chart compares Cmax and AUC pharmacokinetic parameters relative to reference values for hepatic cirrhosis, mild and moderate hepatic impairment, mild/moderate renal impairment, hemodialysis, CYP2D6 polymorphism, age over 60, and gender differences (female/male). The x-axis represents change relative to the reference value, ranging from 0 to 3.5.*

FDA Label Image

Image (Dcddf00d F2f2 4044 B94a 13658bf2ab59 03)

A scatter plot graph showing fold change and 90% confidence intervals for venlafaxine pharmacokinetic parameters (Cmax, AUC, ODV) when coadministered with various interacting drugs including ethanol, diazepam, cimetidine, ketoconazole (in CYP2D6 EMs and PMs), indinavir, metoprolol, imipramine, and lithium. The x-axis represents fold change relative to a reference value ranging from 0 to 3.*

FDA Label Image

Image (Dcddf00d F2f2 4044 B94a 13658bf2ab59 04)

A scatter plot showing fold change and 90% confidence intervals for pharmacokinetic parameters Cmax and AUC of various drugs interacting with venlafaxine hydrochloride. The x-axis represents change relative to a reference value from 0 to 3, and the y-axis lists interacting drugs and their analytes, including ethanol, diazepam, alprazolam, indinavir, metoprolol, risperidone, imipramine, haloperidol, caffeine, tolbutamide, and lithium.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.